Skip to main navigation Skip to search Skip to main content

NOVEL OPIOID COMPOUNDS AND THEIR USES

Research output: Patent

Abstract

The present invention relates to opioid compounds, especially to C14 esters and ethers of naltrexone and analogues thereof. The present invention also relates to compositions, methods and medical uses that employ such compounds. More specifically, the present invention pertains to compounds of formula: and to their use in the treatment of diseases and disorders including pain, hyperalgesia, addiction, substance abuse disorders, stress, anorexia, anxiety, depression, cough, asthma, hypertension, gastrointestinal motility disorder, water retention, cognitive disorders, and locomotor disorders.
Original languageEnglish
Patent numberWO2015082932 (A1)
IPCA61K31/439,A61P25/24,A61P25/30,C07D489/02
Priority date5/12/13
Filing date5/12/14
Publication statusPublished - 11 Jun 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'NOVEL OPIOID COMPOUNDS AND THEIR USES'. Together they form a unique fingerprint.

Cite this